- Research works
- 85 ▲ 37% vs 2013–17
- Citations
- 816 9.5 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 31% world 28%
Not ranked overall: Pharmatest (Finland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.2×. Every wedge is a field page.
Who are the top researchers at Pharmatest (Finland)?
Ranked on the composite score, Esa Alhoniemi and Jussi M. Halleen lead among researchers whose main affiliation is Pharmatest (Finland).
- 1 Esa Alhoniemi Finland · #306,963 worldwide 202 citations · 15 works
- 2 Jussi M. Halleen Finland · #457,593 worldwide 69 citations · 23 works
Which keywords describe research at Pharmatest (Finland)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer Treatment, Prostate Cancer, Immunotherapy, Inflammation, Breast Cancer, Targeted Therapy, PET Imaging and Genetic Mutations.
- Bone Mineral Density
- Cyclooxygenase-2 Inhibitors
- Parathyroid Hormone
- Drug Resistance
- Cancer Stem Cells
- Tumor Metastasis
- Tumor Targeting
- Bone Resorption
- Osteoarthritis
- Matrix Metalloproteinases
- Mesenchymal Stem Cells
- Genomic Profiling
- Androgen Receptor
- Radiopharmaceuticals
- Clinical Practice Guidelines
- Biomarkers
- Clinical Trials
- Targeted Therapy
- Immunotherapy
- Prostate Cancer
- Cancer Treatment
- Inflammation
- Breast Cancer
- PET Imaging
- Genetic Mutations
- Cancer
- Radioimmunotherapy
- Hormone Therapy
- Bisphosphonates
- Osteonecrosis of the Jaw
- Regeneration
- Cartilage
- Tumor Microenvironment
- Osteoclast Differentiation
- Cardiovascular Risk
- Epithelial-Mesenchymal Transition
- Colorectal Cancer
- Gene Therapy
- Stem Cell Niches
- Prostaglandins
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer Treatment16▲ 71×3 topics
- Prostate Cancer15▲ 114×2 topics
- Inflammation12▲ 5.9×19 topics
- Immunotherapy12▲ 21×6 topics
- Breast Cancer10▲ 41×5 topics
- Targeted Therapy8▲ 44×2 topics
- PET Imaging8▲ 43×3 topics
- Clinical Trials8▲ 15×4 topics
- Genetic Mutations8▲ 18×4 topics
- Biomarkers8▲ 15×4 topics
- Cancer8▲ 6.5×12 topics
- Clinical Practice Guidelines8▲ 16×6 topics
- Radioimmunotherapy8▲ 227×1 topic
- Radiopharmaceuticals8▲ 227×1 topic
- Hormone Therapy8▲ 84×3 topics
- Androgen Receptor7▲ 93×1 topic
- Bisphosphonates7▲ 221×1 topic
- Genomic Profiling7▲ 86×1 topic
- Osteonecrosis of the Jaw7▲ 221×1 topic
- Mesenchymal Stem Cells6▲ 59×2 topics
- Regeneration6▲ 39×2 topics
- Matrix Metalloproteinases6▲ 42×2 topics
- Cartilage6▲ 144×1 topic
- Osteoarthritis6▲ 53×1 topic
- Tumor Microenvironment5▲ 17×3 topics
- Bone Resorption4▲ 179×1 topic
- Osteoclast Differentiation4▲ 179×1 topic
- Tumor Targeting4▲ 33×2 topics
- Cardiovascular Risk4▲ 12×3 topics
- Tumor Metastasis3▲ 66×2 topics
- Epithelial-Mesenchymal Transition3▲ 44×2 topics
- Cancer Stem Cells3▲ 86×1 topic
- Colorectal Cancer3▲ 39×2 topics
- Drug Resistance3▲ 12×2 topics
- Gene Therapy3▲ 14×2 topics
- Parathyroid Hormone3▲ 36×2 topics
- Stem Cell Niches3▲ 86×1 topic
- Cyclooxygenase-2 Inhibitors3▲ 95×1 topic
- Prostaglandins3▲ 95×1 topic
- Bone Mineral Density3▲ 40×2 topics
Which research topics does Pharmatest (Finland) publish most on?
By volume in 2022–2025: Prostate Cancer Treatment and Research, Osteoarthritis Treatment and Mechanisms, Radiopharmaceutical Chemistry and Applications and Inflammatory mediators and NSAID effects.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 2 works
- 2 Osteoarthritis Treatment and Mechanisms Rheumatology 2 works
- 3 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
- 4 Inflammatory mediators and NSAID effects Pharmacology 1 works
- 5 Bone health and treatments Oncology 1 works
- 6 Bone Metabolism and Diseases Molecular Biology 1 works
- 7 Multiple Myeloma Research and Treatments Hematology 0 works
- 8 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
- 9 Cancer Research and Treatments Biotechnology 0 works
- 10 Bone health and osteoporosis research Orthopedics and Sports Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pharmatest (Finland)'s research output changed?
Output in 2018–2022 was 37% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Turku
- University of Turku
- Åbo Akademi University
- Turku University Hospital
- Turku University of Applied Sciences
- Turku Centre for Computer Science
- Turku Centre for Biotechnology
- Turku PET Centre
- Turku City Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.